Software Equity Group

AUGUST 20, 2024

The software landscape is dynamic, and strategic buyers are continuously seeking new and innovative ways to gain a competitive edge. One strategy gaining momentum is the acquisition of high-growth SaaS companies. This trend goes beyond simply acquiring market share; it creates a win-win scenario for both parties.

Investment 52

Investment Management Acquisitions Business 52

M&A Leadership Council

JUNE 12, 2023

Insights & Advice: An Interview with Two Experts By Mark Herndon, Chairman Emeritus, M&A Leadership Council Cybersecurity and IT due diligence has become one of the most challenging, and also one of the most critical areas of due diligence in any environment. Tell us more about that. What is the business trying to accomplish?

IT 52

IT M&A Securities Insurance 52

M&A Leadership Council

SEPTEMBER 9, 2021

By Mark Herndon, Chairman, M&A Leadership Council . The risks of brand damage, customer churn, and substantial costs have brought this topic to the forefront in many recent M&A Leadership Council workshops. Tell us more about that. Mark Dickelman (MD): Start by understanding the value proposition of the deal itself.

IT 52

IT M&A Securities Insurance 52

InvestmentBank.com

SEPTEMBER 18, 2019

They account for $3.67 Those making online, direct-to-consumer (DTC), nutritional supplement purchases—not through Amazon which is ~29%—only accounts for about 3% of all nutritional supplement sales [7]. Simplicity, transparency, and trust fuel the growth of the nutritional supplement industry. until 2025 [2].

Food 52

Food Valuation Acquisitions M&A 52

Mergers and Inquisitions

NOVEMBER 1, 2023

When you hear the words “healthcare private equity,” two thoughts probably come to mind: Wait a minute, isn’t healthcare a risky/growth-oriented sector? Why do PE firms operate there? Don’t they need companies with stable cash flows? In most of the world, healthcare is either government-run or a mixed public/private sector. For example, in the U.S.,

Private Equity 59

Private Equity Healthcare Equities Middle Market 59

Cooley M&A

JANUARY 22, 2021

General Trends in Life Sciences M&A. In contrast, aggregate M&A deal value for the life sciences sector was down nearly 50% when compared to 2019, with the first half of 2020 particularly dismal in the wake of market uncertainty caused by the pandemic.

M&A 40

M&A Mergers and Acquisitions Collaboration Mergers 40

Mergers and Inquisitions

MAY 10, 2023

Asia-Pacific sees ~$1+ trillion of M&A deal activity per year , and SE Asia accounts for only ~10% of that (note that the first image below is only for 9 months of the year, so the full-year numbers are higher): $50 – $100 billion of M&A deal activity per year may seem like a lot, but it’s less than Canada in an average year.

Investment Banking 105

Investment Banking Bank Banking Investment 105

Cooley M&A

APRIL 7, 2017

According to a recent study by SRS of recent private life sciences deals, disputes over earn-outs arose in about one-third (36%) of all milestones that were expected to be hit by September 2016. [1] for a Hematologic Cancer Indication.”

Mergers and Acquisitions 40

Mergers and Acquisitions Negotiation Pharmaceutical IT 40

Cooley M&A

JANUARY 20, 2022

General trends in life sciences M&A. While 2020’s M&A landscape was characterized by whiplash volatility from choppy deal activity in the first half of the year to a surge in volume in the second half, that momentum accelerated in 2021, with no signs of slowing down heading into 2022. driven assets.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Cooley M&A

JANUARY 30, 2024

8] M&A-themed campaigns (sell the company/division or agitation against an announced transaction) made up 49% of all activism campaigns globally, well above the trailing four-year average of 42%. [9] 9] We expect the prevalence of M&A-themed campaigns to remain elevated in 2024 as M&A levels bounce back from 2023 levels.

Private Equity 52

Private Equity M&A Investors Capital 52

Devensoft

AUGUST 24, 2023

Mastering Operations, Cross-Selling, and Cost Efficiencies for Maximizing Value from Integrated Ventures The Power of Synergy and Value Creation Amidst the dynamic and fiercely competitive modern business arena, corporations continually strive to secure a distinct market advantage while fostering expansion. Get a copy to-go.

Business 52

Business Collaboration Mergers and Acquisitions Management 52

Cooley M&A

JUNE 24, 2020

Eliminating the need to obtain this relief from the SEC will save buyers time and legal and accounting expense. One change relating to the use of abbreviated financial statements stands out as a welcome reform for public or pre-public biopharma and life sciences companies. Historical Requirements and Process for Carve-Out Transactions.

Financial Statement 40

Financial Statement Acquisitions Business IT 40

InvestmentBank.com

MAY 18, 2021

The healthcare industry is formed of numerous subsectors including pharmaceutical services, diagnostics, medical technologies, and managed healthcare. Payor services and pharmaceutical services have generated the most return throughout 2016 and in 1Q 2017. The pharmaceutical industry is valued highly given the performance of buyouts.

Healthcare 40

Healthcare M&A Valuation Hospitality 40

Cooley M&A

JANUARY 21, 2022

One year into his administration, President Joe Biden has made clear that aggressive competition policy is on the agenda. With a team of progressives filling leadership roles at the Federal Trade Commission and in the Antitrust Division of the US Department of Justice, companies are able to predict what the next several years may look like.

Mergers and Acquisitions 40

Mergers and Acquisitions Mergers Pharmaceutical IT 40